STAASTAAR Surgical Company

$860M

Q2 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$44M-55.2% YoY

Gross Profit

$33M74.0% margin

Operating Income

-$30M-67.6% margin

Net Income

-$17M-37.9% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+4.1%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$29M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$438M

Total Liabilities

$101M

Stockholders' Equity

$337M

Cash & Equivalents

$167M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$99M	-55.2%
Gross Profit	$33M	$78M	-58.2%
Operating Income	-$30M	$12M	-351.8%
Net Income	-$17M	$7M	-327.8%

STAA Q2 2025 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena